Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Walter C Olson"'
Autor:
Craig L Slingluff, Walter C Olson, Christine A Tran, Arabinda Mandal, Jagathpala Shetty, Mriganka Mandal, Bhupal Ban, Eusebio S Pires, Sara J Adair, Todd W Bauer, John C Herr
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 3 (2024)
Background Sperm acrosomal SLLP1 binding (SAS1B) protein is found in oocytes, which is necessary for sperm-oocyte interaction, and also in uterine and pancreatic cancers. Anti-SAS1B antibody-drug conjugates (ADCs) arrested growth in these cancers. Ho
Externí odkaz:
https://doaj.org/article/42cfd49b28e7416885b335130f1658dc
Autor:
Walter C Olson, Max O Meneveau, Kevin T Lynch, Christine A Tran, Priya Katyal, Craig L Slingluff,
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 2 (2023)
Background Immune-mediated melanoma regression relies on melanoma-reactive T cells infiltrating tumor. Cancer vaccines increase circulating melanoma-reactive T cells, but little is known about vaccine-induced circulating lymphocytes (viCLs) homing to
Externí odkaz:
https://doaj.org/article/47178d74b5a14c51966fd54e06e8bc6a
Autor:
Ileana S Mauldin, Craig L Slingluff, Gina R Petroni, Walter C Olson, Kimberly A Chianese-bullock, Kelly T Smith, Nikole Varhegyi, William W Grosh, Kathleen Haden, Lynn T Dengel, Elizabeth M Gaughan, Varinder Kaur, Rick D Vavolizza
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 9 (2022)
Background A vaccine containing 6 melanoma-associated peptides to stimulate helper T cells (6MHP) is safe, immunogenic, and clinically active. A phase I/II trial was designed to evaluate safety and immunogenicity of 6MHP vaccines plus programmed deat
Externí odkaz:
https://doaj.org/article/1a506d69a6074192a111b9cc4c3d7259
Autor:
Patrick Hwu, Jason Roszik, Gina R Petroni, Walter C Olson, Kimberly A Chianese-bullock, Kelly T Smith, Nikole Varhegyi, Elizabeth Gaughan, Mark Smolkin, Sacha Gnjatic, Nolan A Wages, Emily H Hall, Kathleen Haden, Sapna P Patel
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Background We performed a clinical trial to evaluate safety and immunogenicity of a novel long peptide vaccine administered in combinations of incomplete Freund’s adjuvant (IFA) and agonists for TLR3 (polyICLC) and TLR7/8 (resiquimod). We hypothesi
Externí odkaz:
https://doaj.org/article/51b27bff54f64a76a32d944873fe4395
Autor:
Craig L Slingluff, Gina R Petroni, Walter C Olson, Kimberly A Chianese-bullock, Donna Deacon, Mark Smolkin, William W Grosh, Max O Meneveau, Kevin T Lynch, Elise P Salerno, Elizabeth Woodson, James W Patterson
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Background Experimental cancer vaccines are traditionally administered by injection in subcutaneous tissue or muscle, commonly with adjuvants that create chronic inflammatory depots. Injection of melanoma-derived peptides induces T cell responses; ho
Externí odkaz:
https://doaj.org/article/f51a03367fd14cc38bf39a029258d603
Autor:
Girja S. Shukla, Walter C. Olson, Stephanie C. Pero, Yu-jing Sun, Chelsea L. Carman, Craig L. Slingluff, David N. Krag
Publikováno v:
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-9 (2017)
Abstract Background Our research is focused on using the vaccine draining lymph node to better understand the immune response to cancer vaccines and as a possible source of anti-cancer reagents. We evaluated vaccine draining lymph nodes archived from
Externí odkaz:
https://doaj.org/article/94d536027ee0417ba05e947db001f987
Autor:
Michael J. Weber, Jeffrey E. Gershenwald, Prahlad Ram, Gulsun Erdag, Sofia M. Shea, Lainie Martin, Anthony J. Olszanski, Aubrey G. Wagenseller, Geoffrey R. Weiss, William W. Grosh, Cheryl Murphy Chase, Alison Gaucher, Walter C. Olson, Mark E. Smolkin, Amber L. Shada, Kimberly A. Chianese-Bullock, David L. Brautigan, Kerrington R. Molhoek, Gina R. Petroni, Craig L. Slingluff
Blood cell counts for all patients on study, except lymphocytes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d79ab33c339774d4f6ea667e701fd19
https://doi.org/10.1158/1078-0432.22452717
https://doi.org/10.1158/1078-0432.22452717
Autor:
Kimberly A. Chianese-Bullock, John M. Kirkwood, Marc E. Boisvert, William W. Grosh, Naomi B. Haas, Merrick I. Ross, Mark E. Smolkin, Walter C. Olson, Gina R. Petroni, Craig L. Slingluff
Purpose: Granulocyte/macrophage colony-stimulating factor (GM-CSF) administered locally together with vaccines can augment T-cell responses in animal models. Human experience has been limited to small and uncontrolled trials. Thus, a multicenter rand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::012a3e03f5d179574be4d13fc0327cfb
https://doi.org/10.1158/1078-0432.c.6517693.v1
https://doi.org/10.1158/1078-0432.c.6517693.v1
Autor:
Michael J. Weber, Jeffrey E. Gershenwald, Prahlad Ram, Gulsun Erdag, Sofia M. Shea, Lainie Martin, Anthony J. Olszanski, Aubrey G. Wagenseller, Geoffrey R. Weiss, William W. Grosh, Cheryl Murphy Chase, Alison Gaucher, Walter C. Olson, Mark E. Smolkin, Amber L. Shada, Kimberly A. Chianese-Bullock, David L. Brautigan, Kerrington R. Molhoek, Gina R. Petroni, Craig L. Slingluff
PDF file - 155K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::561536781b10aee656838221d539d3fa
https://doi.org/10.1158/1078-0432.22452714.v1
https://doi.org/10.1158/1078-0432.22452714.v1
Supplementary Figure 2. Increased Ab responses over time to 3 of the 4 peptides assessed.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dcc6335cca2570f397bcb9033c1a298
https://doi.org/10.1158/1078-0432.22456776.v1
https://doi.org/10.1158/1078-0432.22456776.v1